Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Tamarind Hill is an early-stage venture capital firm founded in 2017 and based in Columbus, Ohio, with additional offices in Dublin, Ohio, and Ann Arbor, Michigan. The firm was established by a team of industry leaders with a proven track record of successful exits in the healthcare sector. Tamarind Hill focuses on guiding entrepreneurs in scaling their businesses, particularly in the B2B healthcare landscape.
Currently, Tamarind Hill manages a portfolio of 17 companies, emphasizing investments that enhance patient care and reduce costs. The firm operates with a clear mission to support innovative solutions that address critical challenges in healthcare delivery. Their approach is characterized by deep industry expertise and a commitment to driving meaningful change in the healthcare sector.
Tamarind Hill specializes in three primary areas within the B2B healthcare sector: decentralizing care, enhancing the economics of care, and improving supply chain efficiencies. The firm targets early-stage investments, specifically at the pre-seed, seed, and Series A stages, with check sizes ranging from $500,000 to $3 million.
Decentralizing care involves facilitating the transition of patient care from high-cost settings to more accessible alternatives, ensuring that care quality is maintained or improved. Enhancing the economics of care focuses on increasing transparency in costs, outcomes, and revenue models to deliver greater patient value at lower costs. Lastly, improving supply chain efficiencies aims to reduce healthcare delivery costs, expedite access, and enhance patient compliance, ultimately leading to better coordination among healthcare entities.
Tamarind Hill's portfolio includes a diverse range of companies that reflect its commitment to B2B healthcare innovation. Notable investments include:
This portfolio showcases Tamarind Hill's focus on innovative solutions that enhance patient care and operational efficiencies within the healthcare sector.
Mark Shary: Managing Partner with extensive experience in healthcare investments and a history of successful exits.
Ben Trumbull: Managing Partner known for his strategic insights and operational expertise in the healthcare sector.
Josh Buehler: Operating Partner who brings a wealth of knowledge in scaling healthcare startups.
Christie Currie: Senior Associate with a focus on supporting portfolio companies and identifying new investment opportunities.
Allison Weiland: Finance and Operations Manager responsible for overseeing financial operations and ensuring efficient fund management.
Dr. Steve Allen: Executive Partner and CEO Emeritus of Nationwide Children's Hospital, providing invaluable insights into pediatric healthcare.
Michael Louge: Executive Partner and former COO/CFO of OhioHealth, bringing financial acumen and operational expertise.
Dr. Jeff DiLisi: Executive Partner and former Health System CEO Advisory Network member, contributing strategic guidance in healthcare leadership.
To pitch Tamarind Hill, founders should use the preferred channel available on their website at tamarind-hill.com. It is essential to include a comprehensive deck that outlines the business model, market analysis, and alignment with Tamarind Hill's investment focus. While specific application forms are not mentioned, a well-structured pitch is crucial.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are beneficial, as they can enhance the chances of securing a meeting with the investment team.
As of April 2025, Tamarind Hill has made 17 total investments, with 2 new investments in the last 12 months. The firm continues to be an active investor in the B2B healthcare sector, reflecting its commitment to supporting innovative solutions.
Tamarind Hill's first fund, established in 2017, is currently being deployed, indicating ongoing activity in the early-stage investment space. The firm has been recognized for its focus on healthcare innovation and its ability to lead investments in promising startups.
What are Tamarind Hill's investment criteria?
Tamarind Hill invests in early-stage B2B healthcare companies, focusing on those that decentralize care, improve the economics of care, and enhance supply chain efficiencies. They typically invest at the pre-seed, seed, and Series A stages, with check sizes ranging from $500,000 to $3 million.
How can I apply or pitch to Tamarind Hill?
Founders can pitch their ideas through the Tamarind Hill website at tamarind-hill.com. It is advisable to include a clear business model, market analysis, and how the startup aligns with their investment thesis.
What makes Tamarind Hill different from other venture capital firms?
Tamarind Hill differentiates itself through its deep industry expertise in healthcare and its commitment to driving meaningful change. The firm actively supports portfolio companies by providing strategic guidance and facilitating connections within the healthcare ecosystem.
What is Tamarind Hill's geographic scope?
The firm primarily invests in North America, focusing on the United States, particularly in the Midwest region. They are open to companies that are deploying or working towards deploying solutions for the global market.
What is Tamarind Hill's post-investment involvement like?
Tamarind Hill adds value to its portfolio companies by leveraging its industry knowledge, providing strategic guidance, and facilitating connections within the healthcare sector. They aim to help entrepreneurs scale their businesses effectively.
What is the size of Tamarind Hill's funds?
While specific fund sizes are not disclosed, Tamarind Hill typically invests between $500,000 and $3 million in each portfolio company, indicating a significant commitment to supporting early-stage ventures.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.